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Abstract 
Poly-L-lysine was synthesized via a triethylamine initiated ring-opening polymerization f Z-L-lysine-N'~-carboxyanhydride, 
followed by deprotection ofthe E-amino group. Subsequently he polylysine was sulfamated using a pyridinium-sulfate complex 
to obtain polymers with varying degrees of sulfamation ranging from 0 to 100%. Cytotoxicity of these materials was tested using 
tetrazolium etabolism (MTI') assays with B16F10 and P388 cell lines. Cytotoxicity of sulfamated polylysines with a degree 
of sulfamation of80% and higher was significantly reduced as compared with the native polylysines. Inboth cell lines, LDso of 
the sulfamated materials was higher than 5 mg/ml, which was the highest dose tested. LDso of the native polylysines was lower 
than 0.1 mg/ml in the case of B16F10 and lower than 0.01 mg/ml in the case of P388 cells. Sulfamated polylysines with a 
degree of sulfamation of 80% were used to prepare microspheres (SPLMS). The microspheres were stabilized using glutaral- 
dehyde or oxidized extran as a crosslinking agent. The swelling ratio (defined as V~wollen/Vdr~ed) of the SPLMS in aqueous 
media decreased with increasing ionic strength and crosslink density. The pH (ranging from 3 to 11) had no influence on the 
swelling ratio of SPLMS. The maximal swelling ratio was approximately 35(SPLMS crosslinked with 0.5% glutaraldehyde in 
distilled water). SPLMS could be loaded with adriamycin up to a payload of 60%, which was not influenced by the crosslinking 
method. The adriamycin release was controlled by the ionic strength of the release medium: no drug was released in non-ionic 
medium such as distilled water, while 80% of the drug was released in phosphate buffered saline. This effect of the change in 
ionic strength could be applied to prepare amicrosphere suspension i non-ionic medium such as 5% glucose solution, which 
does not contain free adriamycin. The drug would only be release after intra-arterial dministration f this suspension, due to 
the presence of the blood. 
Keywords: Microsphere; Ion exchange; Hydrogel; Drug delivery; Adriamycin 
1. Introduction 
Cytostatic agents are widely used for the treatment 
of cancer. In general these drugs have a narrow thera- 
peutic window. Due to the high systemic levels of the 
drug needed to achieve sufficiently high drug levels at 
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the tumor site, severe side effects such as cardiomy- 
opathy can occur [ 1,2]. A reduction of the side effects 
can be achieved if the drug is targeted to the site of 
action using microspheres [3,4]. Albumin micros- 
pheres (AMS) for instance have received much atten- 
tion as possible devices for chemoembolization [ 5,6 ]. 
Chemoembolization refers to administration f drug- 
loaded particles of the requisite size ( 15-60/~m), to 
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cause tumor infarction by occlusion or to induce tran- 
sient ischemia within the tumor vasculature, where- 
upon the entrapped rug can be released locally [7]. 
However, the use of AMS for the release of adriamycin 
(ADR) has some drawbacks. The preparation methods 
afford only low payloads (1-10%), and ADR may 
react with the crosslinker during the stabilization proc- 
ess. AMS are somewhat hydrophobic and surfactants 
are needed to resuspend them in aqueous olutions. 
Another problem in the use of ADR-loaded AMS is the 
large burst effect usually observed. In any aqueous 
medium 80-90% of the drug is released within 30 min. 
As a result it is hard to handle the formulation in a 
clinical situation. 
Previously, it has been demonstrated that some of 
these problems do not occur if microspheres are highly 
negatively charged and thus have ion-exchange prop- 
erties. Sulfonated polystyrene ion-exchange micros- 
pheres can be loaded with ADR up to payloads of 35% 
and the drug release is controlled by the ionic strength 
of the medium [ 8 ]. In vivo testing in a liver tumor- 
bearing rat model showed that the toxicity of the 
microsphere-formulated drug was decreased as 
compared with the free drug, thus improving the ther- 
apeutic index [9]. A problem with these sulfonated 
polystyrene microspheres is that they are not degraded 
in the body. Upon repeated treatments accumulation of
foreign material in the liver of the patient could even- 
tually result in adverse ffects. If biodegradable, bio- 
compatible ion-exchange microspheres are used, 
however, this may not be a problem anymore. Recently 
ion-exchange albumin-heparin conjugate microspheres 
(AHCMS) were developed, which were shown to be 
biodegradable and biocompatible and which could be 
loaded with ADR up to payloads of 34% [ 10-13 ]. The 
AHCMS are prepared from a soluble conjugate of albu- 
min and heparin. Pendent amino groups of the lysine 
residues of the albumin are used to crosslink the mate- 
rial in order to prepare stable microspheres. The anionic 
groups of the heparin (such as sulfamate groups and 
carboxylic acid groups) allow ionic interaction with 
the ADR, thus enabling high payloads and ion-con- 
trolled drug release. 
Here we describe the preparation of novel synthetic 
biodegradable ion-exchange microspheres, based on 
polylysine. This polymer was partially sulfamated in 
order to allow crosslinking and to obtain the appropriate 
ion-exchange properties. The synthesis of the polyly- 
sine and sulfamated polylysine and the testing of the 
cytotoxicity of the materials are described. The prepa- 
ration of microspheres from partially sulfamated poly- 
lysine (SPLMS) and their characterization with regard 
to the swelling behavior are reported. Furthermore, the 
ADR loading and in vitro release characteristics of the 
SPLMS are reported. 
2. Materials and methods 
2.1. Materials 
Benzylchloroformate, bis (trichloromethyl) carbon- 
ate (triphosgene), and hexanes were purchased from 
Janssen Chimica, Belgium. Anhydrous hydrogen chlo- 
ride and anhydrous hydrogen bromide were purchased 
from Hoekloos, The Netherlands. Chlorosulfonic acid 
was purchased from Fluka, Belgium. L-Lysine. HC1 
was purchased from Merck, Darmstadt, Germany. Dry 
tetrahydrofuran (THF) and dioxane (Merck) were 
obtained by distillation from metallic sodium. Pyridine 
(Merck) was distilled in the presence of tosylchloride 
prior to use. Dextran T10 with a M,~ of 10 000 was 
obtained from Pharmacia Fine Chemicals, Uppsala, 
Sweden. Highly refined olive oil was obtained from 
Sigma Chemical Company, St. Louis, MO, USA. Glu- 
taraldehyde (25% aqueous olution), obtained from 
Merck, was purified by distillation [14] and adjusted 
to 2.5% and 5% w/v aqueous olutions prior to use. 
Phosphate buffered saline (PBS) was obtained from 
NPBI, Emmer Compascuum, The Netherlands. ADR 
was a kind gift from Pharmachemie, Haarlem, The 
Netherlands. All other reagents were obtained, in the 
highest possible grade, from Merck. 
Thin layer chromatography (TLC) was performed 
with Merck precoated Silica 60 F254 plastic sheets 
(thickness 0.2 mm). Spots were visualized by spraying 
with ninhydrin solution. IR spectra were recorded using 
a Perkin-Elmer 1310 infrared spectrophotometer. 
NMR spectra were recorded using a Bruker AC 250 F 
spectrometer. Elemental analyses were carried out by 
the Laboratory of Chemical Analysis of the University 
of Twente. 
2.2. Synthesis of poly-L-lysine 
Poly-L-lysine (PL, Fig. 1,1) was prepared accord- 
ing to procedures previously described, using a triethy- 
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Fig. 1. Sulfamation of polylysine (1) using the pyridinium-sulfate 
complex (PSC, 2), yielding partially sulfamated polylysine (SPL, 
3); R=H,  SO3. The degree of sulfamation is defined as the per- 
centage of sulfamated lysine residues in the polymer. 
lamine initiated ring-opening polymerization of the 
appropriate N~-carboxyanhydride [ 15,16]. First N "- 
benzyloxycarbonyl-L-lysine (Z-L-lysine) was pre- 
pared, followed by conversion of the E-amino 
group-protected monomer to the NCA using triphos- 
gene. Ring-opening polymerization, using triethylam- 
ine as an initiator, yielded the poly-Z-L-lysine. Finally 
the polymer was deprotected togive PL- HC1. 
Z-L-lysine was prepared as described by Erickson 
and Merrifield [ 17]: upon formation of the copper- 
chelate complex of L-lysine by complexation of L- 
lysine with basic cupric carbonate to protect the 
s-amino group, the e-amino group was protected using 
reaction with benzylchloroformate in the presence of 
NaOH. Subsequently, the copper was removed by 
repeated washing with ethylenediaminetetraacetic acid 
(EDTA). Next, Z-L-lysine-NCA was prepared as 
described by Daly and Poch6 [ 18 ]. In this procedure 
Z-L-lysine, suspended in THF, was reacted with tri- 
phosgene, yielding Z-L-lysine-NCA. After repeated 
recrystallization steps to remove chloride impurities, 
the Z-L-lysine-NCA was polymerized as described by 
Fasman et al. [ 19], using triethylamine as an initiator. 
Subsequently HC1 and HBr were led through the poly- 
Z-L-lysine solution, followed by extensive dialysis of 
the solution against 0.01 M HC1 using cellulose Visk- 
ing® membranes togive the PL. HC1. 
To determine the molecular weight of the poly-Z-L- 
lysine intrinsic viscosities were measured in dimethyl- 
formamide, using an Ubbelohde capillary dilution 
viscometer ( 100 L20, Canon) at 25°C. The molecular 
weight (My) was calculated from the limiting viscosity 
number, [ r/], using the equation given by Daniel and 
Katchalski [20]: 
['q] =2.24 10 -7 (My) 1"26 [dl/g] (1) 
Viscosity measurements of PL. HC1 were done in an 
aqueous olution, using an Ubbelohde capillary dilu- 
tion viscometer ( 100 L20, Canon) at 25°C. The degree 
of polymerization (DP) was calculated from the spe- 
cific viscosity, using Eq. 2. Since this empirical rela- 
tionship was determined for a 1% w/v solution of 
PL. HBr [21], the requisite concentration of PL. HC1 
solution was calculated to be 0.787% w/v. 
log DP=0.791og rhp (c= 1%) +2.46 (2) 
2.3. Sulfamation of poly-L-lysine 
PL can be sulfamated in aqueous alkaline solution, 
using the pyridinium-sulfate complex (PSC, Fig. 1,2). 
This compound has been widely used as a reagent in 
the sulfamation of amines but also for sulfating alco- 
hols, sterols and carbohydrates [ 22 ]. 
The PSC was synthesized according to Dorlars [ 23 ]. 
Pyridine (60 ml) and chloroform (60 ml) were mixed 
and cooled to 2°C. The solution was vigorously stirred 
and chlorosulfonic acid (20 ml) was slowly added in 
small drops over a period of 1 h. Immediately a precip- 
itate was formed and the temperature was kept below 
15°C. After stirring for another 30 min at 10°C, the 
white precipitate was filtered and extensively washed 
with chloroform. 
PL was sulfamated according to the method of War- 
ner and Coleman [24]. In a typical experiment PL. HC1 
(105 mg) was dissolved in distilled water (30 ml). 
The pH of the solution was adjusted to 9.5 using 1.0 N 
NaOH. The mixture was stirred thoroughly at room 
temperature, and the PSC was added in small portions. 
The pH of the reaction medium was maintained at 9.5 
by the continuous addition of 1.0 N NaOH, using a pH 
Stat (614 Impulsomat, Metrohm) until a precipitate 
formed. Then the pH was raised to 11.0. After addition 
of the PSC, the reaction mixture was dialyzed twice 
against 0.2 M aqueous NaC1 and twice against distilled 
water. Subsequently the sulfamated PL (SPL, see 
Fig. 1,3) was freeze-dried and stored at 4°C. The 
degree of sulfamation ( DS = Y / (X + Y) × 100%, with 
Y: fraction R = SO3 and X: fraction R = H) was cal- 
culated from the 1H-NMR spectrum in D20. 
2.4. In vitro toxicity testing of sulfamated polylysines 
Toxicity of soluble sulfamated polylysines was eval- 
uated using a tetrazolium-based colorimetric assay 
[ 25 ]. In this test, viability of cells is assessed by the 
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metabolism ofa water-soluble t trazolium dye, 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro- 
mide (MTT), into insoluble formazan salts. 
Cytotoxicity was tested using two cell lines, B I6F10 
colon carcinoma nd P388 murine leukemia, which 
grow in monolayer or in suspension, respectively. 
B16F10 cell suspensions (20000 cells per ml 
medium) were prepared in EMEM (Earle's Minimum 
Essential Medium, ICN Flow, Rickmansworth, Herts., 
UK), containing 10% v/v fetal calf serum (Imperial 
Ltd., UK), supplemented with 1% w/v sodium pyru- 
vate, 1% v/v non-essential amino acids, 1.5% v/v vita- 
mins and 1% v/v L-glutamine. P388 cell suspensions 
were prepared in RPMI medium (ICN Flow), contain- 
ing 10% v/v fetal calf serum (Imperial Ltd.), supple- 
mented with 1% v/v L-glutamine. 
Cells were seeded into a 96-well plate, using 100/zl 
of cell suspension per well. Sulfamated polylysines ( 10 
mg) were dissolved in 1 ml of the respective medium 
and serial dilutions were prepared. Subsequently sul- 
famated polylysine solutions ( 100/zl) were added to 
each well to give final concentrations of 0.01, 0.1,0.5, 
1.0 and 5.0 mg/ml (BI6F10: n=4, P388: n=3;  con- 
trois: B16F10: n=20, P388: n=5) .  After 67 h incu- 
bation at 37°C, MTT was added and cells were 
incubated for 5 more hours at 37°C. After this time, 
suspensions were centrifuged at 2000 rpm and the 
medium was removed. The formazan crystals were dis- 
solved in DMSO (200 /xl/well) and the absorbance 
was measured at 550 nm, using an automatic Titertek 
Multiscan Plus plate reader (ICN Flow). 
2.5. Oxidation of dextran 
In this reaction vicinal diols of dextran are converted 
into dialdehydes. Dextran was oxidized using sodium 
metaperiodate as described by Schacht et al. [26,27]. 
In a typical experiment dextran T10 (12.15 g) was 
dissolved in 100 ml of distilled water. A solution of 
6.42 g sodium metaperiodate in 100 ml of distilled 
water was added and the mixture was stirred in the dark 
at room temperature for 3 h. KI (20 ml, 4.5 M) was 
added in order to convert iodate to iodine and the mix- 
ture was dialyzed extensively against distilled water at 
4°C and freeze-dried. 
The aldehyde content of the oxidized dextran 
(Dexox) was determined by the hydroxylamine method 
[27,28]. Hydroxylamine hydrochloride (5 ml, 1.0 M) 
was added to a 20 ml aqueous olution of Dexox, con- 
taining approximately 2 mmol aldehydes, calculated 
from IOz consumption. The resulting solution was 
stirred for 24 h at room temperature, to ensure that all 
aldehyde groups had reacted with hydroxylamine 
hydrochloride. The mixture was then titrated poten- 
tiometrically using 0.1 N sodium hydroxide solution. 
The Dexox used in the microsphere preparations had a 
degree of oxidation (DO) of 29%. 
2.6. Preparation of sulfamated polylysine 
microspheres 
SPL microspheres (SPLMS) were prepared from 
SPL with DS = 80__+ 5% (SPL80). Glutaraldehyde sta- 
bilized microspheres were prepared according to meth- 
ods previously described for the preparation of 
albumin-heparin conjugate microspheres [ 10]. To a 
flat-bottomed glass beaker (diameter 60 mm, height 
110 mm) equipped with four baffles (4 mm depth) 
positioned against the wall of the beaker was added 125 
ml of olive oil. A four-bladed axial-flow impeller, 
motor-driven using a IKA-RW20DZM mechanical 
stirrer (Janke & Kunkel, Staufen, Germany) was 
placed in the center of the beaker with a 3 mm distance 
between the baffles and the impeller blade. The impel- 
ler was submerged for two thirds into the oil. After pre- 
stirring for 30 min at 850 rpm, 100 mg of SPL80 
dissolved in 0.6 ml PBS was added. After emulsifica- 
tion for 15 min at 950 rpm, 0.15 ml of a glutaraldehyde 
solution was added giving a final crosslinker concen- 
tration of 0.5 or 1.0% w/v, thus preparing SPLMS05 
and SPLMS 10, respectively. The emulsion was stirred 
at 950 rpm for 3 h whereupon 50 ml of acetone was 
added and the resulting emulsion was stirred for 10 
more minutes. SPLMS05 (or SPLMS 10) were isolated 
by centrifugation for 15 min at 2700 rpm, followed by 
decantation ofthe supernatant. The microspheres were 
washed several times with acetone and finally dried in 
vacuo at 50°C. 
Dexox stabilized SPL microspheres (SPLMSd) were 
prepared using similar procedures. SPL80 ( 100 mg) 
was dissolved in 0.6 ml of PBS and emulsified in 125 
ml prestirred (950 rpm, 30 min) olive oil. After 15 
rain, 0.15 ml of PBS containing 0.02 g of Dexox was 
added and the emulsion was stirred for 24 h. Then 100 
/xl of a NaBH3CN solution (5 M) was added to reduce 
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the imines, and the emulsion was stirred for another 3.5 
h. SPLMSd were collected as described above. 
Glutaraldehyde stabilized and Dexox stabilized PL 
microspheres (PLMS05 and PLMSd) were prepared 
by similar procedures as described for SPLMS. How- 
ever, due to increased viscosity of the PL solutions (as 
compared with SPL solutions of the same concentra- 
tion) a stirring speed of 1050 rpm was applied. 
2.7. Swelling experiments 
The equilibrium swelling of SPLMS and PLMS was 
studied as a function of pH and ionic strength. The 
effect of the pH was studied using citrate and phosphate 
buffers at an ionic strength of 0.4. The effect of the 
ionic strength on the swelling was studied in phosphate 
buffers at pH 7.4. The ionic strength was adjusted using 
NaCI. SPLMS were resuspended in 15 ml of the swell- 
ing medium. The swelling ratio, Q (Eq. 3), was deter- 
mined by measuring the total volume of 90 mg of 
swollen microspheres, resuspended in the swelling 
medium in calibrated vials, after centrifugation at2000 
rpm for 10 min. 
Q = vsw°llen (3) 
Wdried 
2.8. Adriamycin loading of SPLMS 
In a typical experiment, 5 mg of SPLMS was ultra- 
sonically suspended in 1 ml of an ADR solution (7.5 
mg/ml).  This suspension was gently rotated for 20 h 
at 4°C, in the dark. The suspension was then centri- 
fuged, the loading solution was decanted and 1 ml of 
distilled water was added to rinse the microspheres. 
After centrifugation, the washing solution was 
decanted again. This procedure was repeated three 
more times and was subsequently repeated four times 
with 1 ml of acetone to dehydrate the microspheres. 
The microspheres were dried in vacuo for 15 h at 50°C. 
The maximal payload of the microspheres was deter- 
mined using ADR loading solutions of increasing con- 
centration (2.5-12.5 mg/ml).  The amount of ADR 
remaining in the loading solution and the ADR amounts 
in the washing solutions were determined by UV/Vis 
measurements at 494 nm with a Uvikon 930 spectro- 
photometer (Kontron Instruments, Rotkreuz, Switzer- 
land). The payload was calculated from the ADR 
depletion of the loading solution and the ADR recov- 
ered from the washing and dehydration solutions. 
2.9. Adriamycin release from SPLMS 
Release xperiments were carried out using a batch 
system. Microspheres ( _+ 2 rag) were weighed into a 
20-ml polypropylene (PP) vial. Ethanol (200/~1) was 
added and the microspheres were ultrasonically resus- 
pended. At t=0,  20 ml of release medium (PBS or 
distilled water) was added and the vials were put into 
a shaking bath at 37°C. The amplitude of the shaking 
was 2.0 cm and the frequency approximately 2 Hz. At 
intervals, the PP vials were taken from the bath and 
shaken vigorously to homogenize the suspension. A 1- 
ml sample was pipetted from the vial into an 1.5-ml 
Eppendorf® cup. After centrifugation, the supernatant 
was transferred into polystyrene micro-cuvettes and the 
A494 was measured todetermine the amount of released 
ADR. 
3. Results and discussion 
3.1. Synthesis ofsulfamated polylysine 
PL. HC1 was synthesized from L-lysine using a 
multi-step rocedure in an overall yield of 11.6%. As 
can be seen in Table 1, the low overall yield was 
mainly caused by the low yield of the Z-L-lysine-NCA 
preparation step. The low yield of this reaction step was 
due to repeated recrystallizations carried out to reduce 
the Cl-  content. 
The results of the elemental nalysis (Table 1 ) and 
the IH-NMR spectrum (Fig. 2a) revealed that the 
obtained PL was highly pure. This was confirmed by 
TLC and by the IR spectrum (data not shown). 
The molecular weight (Mv) of the poly-Z-L-lysine 
calculated from the limiting viscosity number using Eq. 
1 was 395 000. This corresponds toa degree of polym- 
erization of 1510. The degree of polymerization as 
determined from the specific viscosity of a 0.787% 
solution of poly-L-lysine" HC1 in water and calculated 
using Eq. 2 was 1509, indicating that the deprotection 
of the poly-Z-L-lysine under strong acidic conditions 
did not result in degradation of the polymer. 
Sulfamation of the PL was performed by stepwise 
addition of a pyridinium-sulfate complex (PSC) and 
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Table 1 
Results f-om poly-L-lysine preparation procedure 
Product Yield a (%) Elemental nalysis b (%) 
C H N CI 
Z-L-lysine 71 60.3 (60.0) 
Z-L-Lysine-NCA 25 59.3 (58.8) 
Poly-Z-L-lysine 76 64.4 (64.1) 
Poly-L-lysine- HCI 86 43.3 (43.8) 
7.3 (7.2) 
5.8 (6.3) 
7.0 (6.9) 
8.1 (8.0) 
9.9 (10.0) 
8.9 (9.1) (0.03 c
10.6 (10.7) 
16.7 (17.0) 20.4 (21.5) 
aYield of the separate r action steps; overall yield is 11.6%. 
bCalculated percentages aregiven in parentheses. 
¢C1- content as determined bypotentiometric itration with AgNO3. 
carried out at pH 9.5. Upon addition of high amounts 
of PSC, a precipitate was formed at a PSC/NH2 molar 
ratio of approximately 0.7. This precipitate could be 
dissolved by raising the pH to 11 and adding the 
remainder of the PSC. This precipitation is probably 
due to intra-and intermolecular ionic interaction 
between the sulfamate groups and the remaining amino 
groups, which is impeded at higher pH and higher 
degrees of sulfamation. After dialysis and freeze-dry- 
ing of the products, sulfamated PLs (SPLs) were 
obtained in a yield of 95%. 
The ~H-NMR spectrum of 100% sulfamated PL is 
shown in Fig. 2b. The &CH2 and the/3-CH2 protons 
of PL- HC1 are located at 6--- 1.6-1.9 ( see Fig. 2a and 
Table 2). In SPL the &CH2 protons of a sulfamated 
lysine residue shift upfield to 6= 1.47-1.65 (see 
Fig. 2b and Table 2). A change in the chemical shift 
of the &CH2 protons, without a change in the chemical 
shift of the e-CH2 protons upon sulfamation of a lysine 
residue, is expected on the basis of literature data of 
aliphatic ammonium salts and alkyl sulfonamides. The 
chemical shifts of a-CH2 and /3-CH2 protons of ali- 
phatic ammonium salts (comparable with e-CH2 and 
&CH2 protons of lysine. HCL) are 2.9-3.1 and 1.7- 
1.8, whereas the chemical shifts of these a-CH2 and/3- 
CH2 protons of alkyl sulfonamides (comparable with 
e-CH2 and &CH2 protons of sulfamated lysine) are 
2.9-3.45 and 1.45-1.6, respectively [29]. 
If the PL is only partially sulfamated, the 6-CH2 
protons of the unsulfamated NH2-residues will be 
located at 6 = 1.65-1.9 while the &CH2 protons of sul- 
famated residues will be found at 6= 1.47-1.65. This 
is confirmed by the results obtained from the 2D-~H -
NMRexperimentsofPL(Fig. 3a),SPL100(Fig. 3b) 
and partially sulfamated SPL (Fig. 3c). In the PL 
spectrum, the interaction between the e-CH2 protons at 
6=2.9-3.2 and the &CHe (and fl-CHe) protons at 
6= 1.6-1.9 is clear. In the SPL100 spectrum, no inter- 
action between the E-CH2 protons (6=2.9-3.2) and 
the fl-CH2 protons (6= 1.65-1.9) is present. Only 
interaction between the E-CH: protons and the &CH2 
protons of the sulfamated lysine residues (6 = 1.47- 
1.65) is seen. In the partially sulfamated PL, both inter- 
actions are evident, indicating that the 6-CHe protons 
absorb at different 6 depending on the sulfamation of 
the e-NH2 group. Since the relative peak areas in a 1H- 
NMR spectrum are proportional to the number of 
absorbing protons, the DS can be calculated from the 
peak areas of the &CH2 and/3-CH2-protons using Eq. 
4. 
A1.55 
DS-  ×2X 100% (4) 
Ai.55 q- A1. 7 
with A1.55 being the &CH2 peak area of a sulfamated 
lysine residue, absorbing at 6= 1.48-1.65 and A1. 7 
being the &CH2 (of the unsulfamated lysine resi- 
dues) +fl-CH2 peak area absorbing at 6= 1.65-1.9. 
The DS, calculated from the IH-NMR spectra of several 
SPLs, is depicted in Fig. 4. This graph shows that the 
DS can be controlled by the initial molar atio of PSC/ 
PL-e-NH2 groups. 
3.2. In vitro cytotoxicity o f  sulfamated polylysines 
Polylysine is known to be toxic both in vitro [25,30] 
and in vivo [ 31,32]. Cytotoxicity of the polylysine is 
probably due to the electrostatic interactions ofthe pos- 
itively charged polymer with one or more essential, 
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Fig. 2. J H-NMR spectra of (sulfamated) poly-L-lysines in D20. (a) Poly-L-lysine" HC1; (b) 100% sulfamated poly-L-lysine. 6 = 5.6-5.9:H20 
resonance, other peak assignments are given in Table 2. 
Table 2 
Assignment ofPL and SPL100 ~H-NMR resonances 
Group Chemical shift region (ppm) a 
PL SPL100 
a-CH 4.2-4.4 4.2 -4.4 
fl-CH2 1.6-1.9 1.65-1.9 
"y-CH 2 1.3-1.6 1.3 -1.47 
6-CH2 1.6-1.9 (1.7-I .8) 1.47-1.65 ( 1.45-1.6) 
e-CH 2 2.9-3.2 (2.9-3.1) 2.9 -3.2 (2.9-3.45) 
aLiterature values of o~-CH2 and fl-CH2 resonances of aliphatic 
ammonium salts and alkyl sulfonamides are given in parentheses 
129]. 
mostly negatively charged, cell components or struc- 
tures, blocking or altering their function [30,31]. 
Molecular weight of the polymer also plays an impor- 
tant role in this process. Arnold et al. [32] demon- 
strated that poly-L-lysine toxicity increased with 
increasing molecular weight. 
In vitro cytotoxicity experiments showed that the 
toxicity of the polylysines was reduced significantly if
the amino groups were sulfamated. Fig. 5 shows the 
relative viability of B 16FI0 cells after incubation with 
PL, SPL100 or SPL80. The sulfamated polylysines 
were tolerated at a concentration of approximately 1 
mg/ml,  whereas the polylysine was already toxic at the 
lowest tested ose (0.01 mg/ml ) .  
The same trend was observed with the P388 MTT 
assay (Fig. 6), sulfamatedpolylysines (with DS rang- 
ing from 80% to 100%) were not toxic up to a dose of 
5 mg/ml,  whereas the unsulfamated PL was already 
toxic at the lowest ested ose ( 0.01 mg / ml). The large 
spread of the P388 data was due to plate variation. 
These results show that the toxicity of the PL was 
reduced significantly if the polymer was sulfamated at 
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Fig. 3. Contour plots of 2DJH-NMR spectra in D20 from 6 = 3.2 to 
6= 1.2. (a) Poly-L-lysine. HCI; (b) 100% sulfamatedpoly-L-lysine; 
(c) partially sulfamated poly-L-lysine ( SPL80 ). 
100- 
80-  e- 
..? 
60 ' 
- i  
'~ 40-  
20 ' 
"O 
120 
looJ 
t l t  t 
0T ! ! i i 
0 1 2 3 4 5 
molar ratio PSC/PL-NH2 
Fig. 4. Degree of sulfamation of polylysine after reaction with pyri- 
dine-sulfate complex as a function of the initial PSC/PL-NH2 ratio, 
as calculated from ~H-NMR spectra of the resulting SPLs. 
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Fig. 5. Relative viabil ity of  B 16FI 0 cells after incubation with (sul- 
famated) polylysines, as determined using a MTT assay. O: PL; (3; 
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Fig. 6. Relative viability of P388 cells after incubation with ( sulfa- 
mated) polylysines, as determined using a MTT assay. 0:  PL; (3: 
SPL80; IS]: SPL95; A: SPLI00. Error bars indicate SD. 
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Table 3 
Results from SPL80 and PL microsphere preparation 
Type Crosslinking Yield after 
preparation a 
(%) 
10-40 p,m 
fraction 
(%) 
SPLMS05 0.5% glutaraldehyde 73 65 
SPLMS10 1.0% glutaraldehyde 71 72 
SPLMSd oxidized dextran 70 39 
PLMS05 0.5% glutaraldehyde 75 61 
PLMSd oxidized dextran 68 42 
aBased on the initial amount of SPL or PL. 
a DS of 80% and higher. There were no significant 
differences incytotoxicity between the SPLs with a DS 
ranging from 80 to 100%. 
3.3. Preparation and adriamycin loading and release 
properties of sulfamated polylysine microspheres 
Pilot experiments showed that gelation of SPL solu- 
tions by addition of glutaraldehyde depended on the 
DS. At low DS ((90%), gels were rapidly formed upon 
addition of glutaraldehyde. At a DS of 95%, the vis- 
cosity of the polymer solution increased, indicating 
some crosslinking, however, this was insufficient o 
cause gelation. At DS = 100%, no changes in viscosity 
were observed at all. At DS = 35% solubility problems 
were manifest. These were probably due to the intra- 
molecular ionic interactions of the E-amino groups and 
the sulfamate groups. From these results it is concluded 
that a DS in a range of 60-90% is optimal for the 
preparation of SPLMS. SPLs with a DS in this range 
25" 
,0 | | 
ft. 
0 | i ! | 
2 4 6 8 10 12 
pH 
Fig. 7. Swelling ratio Q of SPLMS and PLMS as a function of the 
pH at ionic strength, 1=0.4; IS]: SPLMS05; A: SPLMS10; O: 
SPLMSd; B: PLMS05; O: PLMSd. Error bars indicate SD. 
contain sufficient E-amino groups for crosslinking, 
whereas the relatively high amount of sulfamate groups 
ensures olubility and ion-exchange properties of the 
polymer. 
Based on the results from the cytotoxicity and gela- 
tion experiments SPL with a DS of 80% (SPL80) was 
chosen as matrix material for the SPLMS. Micros- 
pheres were prepared from SPL80 and PL by the emul- 
sion stabilization method using glutaraldehyde or 
Dexox as crosslinking agents. The aldehyde group con- 
tent of the latter crosslinking agent could be varied by 
changing the initial molar periodate/glucoside ratio 
during the oxidation procedure of the dextran. The 
Dexox used in the microsphere preparations was pre- 
pared at an initial periodate/glucoside ratio of 0.4. The 
oxidation reaction was complete within 30 min and 
resulted in a DO of 29%. GPC measurements which 
were carried out using dextran fractions with a known 
narrow molecular weight distribution, indicated that he 
dextran was not degraded uring the oxidation proce- 
dure (data not shown). 
The microspheres were prepared ina yield of approx- 
imately 70% (Table 3). Crosslinking with glutaral- 
dehyde resulted mainly in the formation of spherical 
particles whereas in the crosslinking with Dexox also 
irregularly shaped, large particles were formed. Con- 
sequently, the fraction of microspheres between 10 and 
40/xm, which was obtained by sieving with 10-and 40- 
/xm sieves, was considerably smaller in the case of 
Dexo× crosslinked microspheres, ascompared with glu- 
taraldehyde crosslinked spheres (Table 3). 
The swelling ratios of the microspheres a a function 
of the pH are shown in Fig. 7. The swelling ratio of 
the SPLMS is independent of the pH, whereas the 
swelling ratio of PLMS decreased at pH)7. This can 
be explained by the ionization of the pendent groups. 
Sulfamate groups are strong acidic groups with a pK 
of approximately 1. At pH 3 and higher, there will be 
no change in the ionization of these groups, and the 
degree of swelling does not change. In the case of 
PLMS, the pendent E-amino groups have a pK of 
approximately 8. At high pHs, these groups are depro- 
tonated and the repulsive forces in the network that are 
due to electrostatic interactions are decreased resulting 
in a decrease of the degree of swelling. 
The influence of the ionic strength on the swelling 
behavior is shown in Fig. 8. This graph shows that the 
repulsion of the equally charged groups in the network 
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Fig. 8. Swelling ratio Q of SPLMS and PLMS as a function of the 
ionic strength at pH=7.4; C]: SPLMS05; A: SPLMSI0; O: 
SPLMSd; I1: PLMS05; O: PLMSd. Error bars indicate SD. 
is decreased by the counter ions in the medium, thus 
reducing the swelling ratio at higher ionic strength. In 
distilled water (ionic strength =0) the swelling ratio is 
maximal and most profound in the case of SPLMS05, 
which swell up to a swelling ratio of 35 (data not 
shown). 
Fig. 7 and Fig. 8 show that the swelling ratio Q 
(Eq. 3) of the SPLMS05 is higher than that of 
SPLMS 10. This can be explained by increased retrac- 
tive forces at increased crosslink densities, which pre- 
vent the hydrogel from expanding. Previously this was 
also observed with AHCMS of which the degree of 
swelling decreased with increased crosslink density 
[10,33]. 
Fig. 7 and Fig. 8 also show that SPLMS05 swell 
more than SPLMSd, whereas the opposite trend is 
observed with PLMS. A speculative explanation is the 
difference in glutaraldehyde crosslinks that may occur 
due to the high amount of e-amino groups present in 
PL in comparison with the amount of e-amino groups 
of SPL. The exact crosslinking mechanism of glutar- 
aldehyde is not fully understood. It is generally 
accepted that the initial step is the formation of an imine 
by the reaction of an aldehyde group with a primary e- 
amino group [34]. Subsequently, various reactions 
may occur, with the imine acting as an intermediate, 
the most important being the formation of pyridinium 
compounds by oxidative cyclization of the imine [ 35- 
37]. However, unsaturated a,/3-condensation ligo- 
mers (with n= 1-40) may also be formed due to 
reactions involving conjugated imines [34,36]. If 
many e-amino groups are present like in the case of PL, 
it is conceivable that more, shorter crosslinks are 
formed while in the case of SPL, which contains fewer 
e-amino groups, extended crosslinks are formed. In the 
case of Dexox crosslinked microspheres, the length of 
the crosslinks is mainly determined by the number of 
reaction sites along the dextran molecule, which may 
be different for PL and SPL. Therefore, more research 
on the structure of both glutaraldehyde and Dexox cros- 
slinks is necessary to provide an adequate xplanation 
for the observed swelling behavior. 
In comparison with AHCMS, the swelling ratio of 
the SPLMS and the PLMS is considerably higher. 
AHCMS were shown to have a maximal swelling ratio 
of 11 [ 10,33], whereas the maximal swelling ratio of 
SPLMS was almost 35. Chemoembolization therapy 
requires microspheres with a diameter of 10-50 ~m in 
the swollen state. In order to obtain SPLMS suitable 
for chemoembolization therapy smaller SPLMS (dry 
size) have to be prepared. 
SPLMS and PLMS are hydrophilic and easy to resus- 
pend in aqueous solutions. Since SPLMS also have 
anion-exchange properties, they could be loaded with 
ADR by incubating the microspheres in an ADR solu- 
tion. This procedure allowed efficient drug loading and 
high ADR payloads of SPLMS. Fig. 9 shows that the 
maximum ADR payload of SPLMS was approximately 
60%, and was reached at a ADR/MS weight ratio of 
1.5. This indicates that the efficiency of the loading 
process was almost 100% up to this ratio. Fig. 9 also 
shows that there was influence from neither the degree 
of crosslinking nor the kind of crosslinker used on the 
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Fig. 9. Influence of the ADR/MS ratio on the payload after 24 h of 
drug loading. MS (5 mg) were resuspended in 1 ml of ADR solution 
(2.5-12.5 mg/ml). [~: SPLMS05; A: SPLMS10; O: SPLMSd; I1: 
PLMS05; O: PLMSd. 
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Fig. 10. Cumulative ADR release from SPLMS in distilled water at 
37°C. At t = 90 min PBS was added to increase the ionic strength of 
the release medium, r-q: SPLMS05; G: SPLMS10; O: SPLMSd. 
loading capacity. Furthermore, Fig. 9 shows that 
PLMS, which have a net positive charge, could only 
be loaded with ADR up to a few percent. 
Fig. l0 shows that the ADR release from SPLMS 
was controlled by the ionic strength of the medium. As 
the microspheres were suspended in distilled water at 
37°C, no ADR was released at all. After 90 min, PBS 
was added to the suspension to give an ionic strength 
half that of PBS. Upon increasing the ionic strength of 
the medium, ADR was instantaneously released. 
Fig. 11 shows that ADR SPLMS released 50% of 
the drug within 1 h after suspension in PBS. Fig. l0 
and 11 also show that neither the degree of crosslinking 
nor the crosslinking agent influenced the release profile. 
The ionic strength in the experiment shown in Fig. l0 
was half that of PBS. As can be observed from Fig. l0 
and 11 this difference had no influence on the release, 
leo 
in both cases approximately 80% of the ADR was 
released within 6 h. The remaining drug was not 
released within the next 18 h. It is possible that this 
drug is covalently bound to the matrix after reaction 
with aldehyde groups that may still be present after 
crosslinking. It is also possible, however, that the elec- 
trostatic bond of the drug with the matrix is stabilized 
by self-association f ADR. This phenomenon was also 
observed in soluble heparin-ADR complexes [ 38 ] and 
a possible cause of incomplete ADR release from 
AHCMS [ 11 ]. 
In comparison with AHCMS, the maximum ADR 
payload of SPLMS is much higher. AHCMS could be 
loaded up to a payload of 34% [ 11 ], whereas the 
SPLMS could be loaded up to a payload of 60%. 
AHCMS release approximately 30% of the ADR in 
non-ionic medium [11], while 0% of ADR was 
released from SPLMS. Both types of microspheres 
released 80-90% of the drug in physiological salt solu- 
tion. These results suggest that the ion-exchange prop- 
erties of SPLMS predominantly control the drug 
binding and release, whereas in the case of AHCMS, 
hydrophobic interactions also play an important role. 
Since SPLMS can in principle be modified by intro- 
duction of amino acids with uncharged or hydrophobic 
pendent groups in the polymer backbone, these micros- 
pheres can in principle be used as a model system to 
study the interaction of ADR with AHCMS. Whether 
SPLMS are suitable chemoembolization devices which 
could be used if high payloads are necessary depends 
on the in vivo behavior of these microspheres. This 
remains to be studied. 
4. Conc lus ions  
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Fig. 11. Cumulative ADR release from SPLMS in PBS at 37°C. IS]: 
SPLMS05; A: SPLMS 10; O: SPLMSd. 
It was shown that polylysine can be sulfamated in a 
controlled way to obtain polymers ranging from 100% 
cationic to 100% anionic. Upon sulfamation, the in 
vitro cytotoxicity of polylysine was significantly 
reduced at degrees of sulfamation of 80% and higher. 
Sulfamated polylysines with a degree of sulfamation 
of 80% could be used to prepare microspheres 
(SPLMS) with a dry size of 10-40/zm in diameter, by 
techniques developed for the preparation of AMS and 
AHCMS. In comparison with AHCMS, the ADR load- 
ing and release characteristics of SPLMS were 
improved. The maximal payload was increased by 25 % 
up to 60%, whereas release in a non-ionic medium was 
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completely absent. This indicates that a suspension of  
drug-loaded microspheres could be prepared in non- 
ionic medium like 5% glucose solution, without any 
drug release taking place. Upon intra-arterial adminis- 
tration of  this suspension, drug release is triggered by 
ions in the blood. 
These results show that sulfamated polylysines can 
be used to prepare ion-exchange microspheres which 
in turn have great potential as ADR delivery devices. 
In order to evaluate these microspheres for chemoem- 
bolization therapy, in vivo behavior of  the sulfamated 
polylysine microspheres remains to be studied. 
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